Original paper
Novel orally bioavailable EZH1/2 dual inhibitors with greater antitumor efficacy than an EZH2 selective inhibitor
Abstract
Polycomb repressive complex 2 ( PRC 2) methylates histone H3 lysine 27 and represses gene expression to regulate cell proliferation and differentiation. Enhancer of zeste homolog 2 ( EZH 2) or its close homolog EZH 1 functions as a catalytic subunit of PRC 2, so there are two PRC 2 complexes containing either EZH 2 or EZH 1. Tumorigenic functions of EZH 2 and its synthetic lethality with some subunits of SWI tch/Sucrose Non‐Fermentable ( SWI /...
Paper Details
Title
Novel orally bioavailable EZH1/2 dual inhibitors with greater antitumor efficacy than an EZH2 selective inhibitor
Published Date
Aug 8, 2017
Journal
Volume
108
Issue
10
Pages
2069 - 2078
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History